Rezolute GAAP每股收益-0.26美元，差0.01美元

2025-09-18 16:48

Rezolute press release (NASDAQ:RZLT): Q4 GAAP EPS of -$0.26 misses by $0.01.
Cash, cash equivalents and investments in marketable securities were $167.9 million as of June 30, 2025, compared with $127.1 million as of June 30, 2024.

More on Rezolute

Rezolute: FDA Pivotal Trial Alignment Change Further Bolsters Ersodetug
Rezolute, Inc. (RZLT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Rezolute ticks higher following disclosure of CFO stock buy
Seeking Alpha’s Quant Rating on Rezolute
Historical earnings data for Rezolute